The results of the current study showed that COPB2 is overexpressed in HCC tissues, associated with HCC prognosis, and plays a crucial role in the proliferation, migration, and invasion of HCC cell lines in vitro, indicating that COPB2 is a novel prognostic biomarker and promising therapeutic target for HCC. The gene discussed is COPB2; the disease is hepatocellular carcinoma.